The antitumor activity of scutellarin was reported through inhibiting proliferation and inducing apoptosis of HepG2 cells in liver cancer [167], attenuating the development of fibrosarcoma and inhibiting cancer cell metastasis [168], and inhibiting the invasive potential of melanoma cell lines by suppressing the EMT and angiogenesis through the PI3K/Akt/mTOR signalling pathway [169]. Here, AKT1 is linked to liver cancer.